MoonLake Immunotherapeutics
MLTX
$17.80
-$0.20-1.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.15% | 3.55% | -10.49% | -11.47% | 7.17% |
| Total Receivables | 18.36% | 21.06% | 17.98% | 14.09% | 5.06% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 44.19% | -14.44% | -1.02% | 16.60% | -1.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.94% | 2.55% | -9.72% | -10.03% | 6.74% |
|
|
|||||
| Total Current Assets | -5.94% | 2.55% | -9.72% | -10.03% | 6.74% |
| Net Property, Plant & Equipment | 11.48% | -15.40% | -13.19% | -11.58% | -9.44% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 125.50% | 1.53% | -65.41% | -0.06% | -- |
| Total Assets | -5.67% | 2.44% | -9.95% | -10.01% | 6.97% |
|
|
|||||
| Total Accounts Payable | 6,305.48% | -44.10% | 8.47% | 4,200.00% | -92.31% |
| Total Accrued Expenses | -52.28% | -5.35% | 85.46% | 20.05% | 0.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.45% | -17.68% | -3.29% | 8.24% | 4.37% |
| Total Finance Division Other Current Liabilities | 27.51% | 7.89% | 21.29% | -62.54% | 247.66% |
| Total Other Current Liabilities | 27.51% | 7.89% | 21.29% | -62.54% | 247.66% |
| Total Current Liabilities | 1.40% | -5.98% | 76.78% | 14.09% | 6.76% |
|
|
|||||
| Total Current Liabilities | 1.40% | -5.98% | 76.78% | 14.09% | 6.76% |
| Long-Term Debt | 33.63% | 0.49% | 0.49% | 0.49% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 131.28% | -23.05% | -41.87% | -26.80% | -21.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -4.36% | 7.09% | -13.69% |
| Total Liabilities | 22.01% | -2.59% | 20.55% | 3.52% | 302.09% |
|
|
|||||
| Common Stock & APIC | 2.55% | 11.27% | 0.75% | 0.48% | 0.48% |
| Retained Earnings | -15.06% | -15.59% | -21.08% | -20.04% | -16.95% |
| Treasury Stock & Other | -46.69% | 117.27% | -46.54% | -78.22% | -52.23% |
| Total Common Equity | -16.57% | 5.39% | -18.33% | -13.20% | -8.80% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -16.57% | 5.39% | -18.33% | -13.20% | -8.80% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -45.76% | -16.76% | -22.92% |
| Total Equity | -16.57% | 4.56% | -18.65% | -13.24% | -9.00% |
|
|
|||||